My Bibliography

select

Stanton SE, Anderson KG, Bruno TC, Capitini CM, Disis ML, McQuade J, Radvanyi L, Vanpouille-Box C, Wargo J, Baines KJ, Hong MMY, Rajeh A, Kim RH, Awadalla P, Hughes LK, Maleki Vareki S. SITC strategic vision: prevention, premalignant immunity, host and environmental factors. J Immunother Cancer. 2025 Mar 28;13(3). doi: 10.1136/jitc-2024-010419. Review. PubMed PMID: 40154956; PubMed Central PMCID: PMC11956356.

select

Liao JB, Dai JY, Reichow JL, Lim JB, Hitchcock-Bernhardt KM, Stanton SE, Salazar LG, Gooley TA, Disis ML. Magnitude of antigen-specific T-cell immunity the month after completing vaccination series predicts the development of long-term persistence of antitumor immune response. J Immunother Cancer. 2024 Nov 9;12(11). doi: 10.1136/jitc-2024-010251. PubMed PMID: 39521614; PubMed Central PMCID: PMC11552009.

select

Stanton S, Schmitz F, Copeland W, DellAringa J, Newhall K, Disis M. Populations of triple negative and hormone receptor positive HER2 negative breast tumors share immune gene profiles. Res Sq. 2024 Aug 2;. doi: 10.21203/rs.3.rs-4542494/v1. PubMed PMID: 39149486; PubMed Central PMCID: PMC11326399.

select

Mohammed A, Dashwood RH, Dickinson S, Disis ML, Jaffee EM, Johnson BD, Khleif SN, Pollak MN, Schlom J, Shoemaker RH, Stanton SE, Wondrak GT, You M, Zhu H, Miller MS. Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report. J Cancer Prev. 2021 Dec 30;26(4):309-317. doi: 10.15430/JCP.2021.26.4.309. PubMed PMID: 35047458; PubMed Central PMCID: PMC8749317.

select

Liao JB, Gwin WR, Urban RR, Hitchcock-Bernhardt KM, Coveler AL, Higgins DM, Childs JS, Shakalia HN, Swensen RE, Stanton SE, Tinker AV, Wahl TA, Ancheta RG, McGonigle KF, Dai JY, Disis ML, Goff BA. Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates. J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-003122. PubMed PMID: 34531249; PubMed Central PMCID: PMC8449961.

select

Yang M, Hu X, Bao W, Zhang X, Lin Y, Stanton S, Haffty B, Hu W, Kang Y, Wei S, Zhang L. Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015. Am J Cancer Res. 2021;11(6):3201-3211. eCollection 2021. PubMed PMID: 34249455; PubMed Central PMCID: PMC8263668.

select

Stanton SE, Gad E, Ramos E, Corulli L, Annis J, Childs J, Katayama H, Hanash S, Marks J, Disis ML. Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients. NPJ Breast Cancer. 2021 May 11;7(1):50. doi: 10.1038/s41523-021-00257-1. PubMed PMID: 33976232; PubMed Central PMCID: PMC8113561.

select

Stanton SE, Gad E, Corulli LR, Lu H, Disis ML. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets. Vaccine. 2019 Jun 12;37(27):3552-3561. doi: 10.1016/j.vaccine.2019.05.024. Epub 2019 May 21. PubMed PMID: 31126858; PubMed Central PMCID: PMC7087478.

select

Stanton SE, Davidson NE. Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?. Nat Rev Clin Oncol. 2017 Dec;14(12):715-716. doi: 10.1038/nrclinonc.2017.125. Epub 2017 Aug 8. PubMed PMID: 28786414.

select

Stanton SE, Disis ML. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. 2016;4:59. doi: 10.1186/s40425-016-0165-6. eCollection 2016. Review. PubMed PMID: 27777769; PubMed Central PMCID: PMC5067916.

select

Stanton SE, Adams S, Disis ML. Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review. JAMA Oncol. 2016 Oct 1;2(10):1354-1360. doi: 10.1001/jamaoncol.2016.1061. PubMed PMID: 27355489.

select

Tan AR, Stanton SE. Immune Checkpoint Blockade: A New Strategy for the Treatment of Breast Cancer. The International journal of targeted therapies in cancer. 2016 June.

select

Stanton SE, Eary JF, Marzbani EA, Mankoff D, Salazar LG, Higgins D, Childs J, Reichow J, Dang Y, Disis ML. Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo. J Immunother Cancer. 2016;4:27. doi: 10.1186/s40425-016-0131-3. eCollection 2016. PubMed PMID: 27190628; PubMed Central PMCID: PMC4869363.

select

Stanton SE, Disis ML. Designing vaccines to prevent breast cancer recurrence or invasive disease. Immunotherapy. 2015;7(2):69-72. doi: 10.2217/imt.15.5. PubMed PMID: 25713984; PubMed Central PMCID: PMC4412310.

select

Disis ML, Stanton SE. Triple-negative breast cancer: immune modulation as the new treatment paradigm. Am Soc Clin Oncol Educ Book. 2015;:e25-30. doi: 10.14694/EdBook_AM.2015.35.e25. PubMed PMID: 25993181.

select

Cherryholmes GA, Stanton SE, Disis ML. Current methods of epitope identification for cancer vaccine design. Vaccine. 2015 Dec 16;33(51):7408-7414. doi: 10.1016/j.vaccine.2015.06.116. Epub 2015 Aug 1. Review. PubMed PMID: 26238725; NIHMSID:NIHMS782506.

select

Stanton SE, Ward MM, Christos P, Sanford R, Lam C, Cobham MV, Donovan D, Scheff RJ, Cigler T, Moore A, Vahdat LT, Lane ME, Chuang E. Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity. BMC Cancer. 2015 Apr 11;15:267. doi: 10.1186/s12885-015-1298-6. PubMed PMID: 25885598; PubMed Central PMCID: PMC4403678.

select

Marquez JP, Stanton SE, Disis ML. The antigenic repertoire of premalignant and high-risk lesions. Cancer Prev Res (Phila). 2015 Apr;8(4):266-70. doi: 10.1158/1940-6207.CAPR-14-0314. Epub 2015 Jan 8. Review. PubMed PMID: 25572327; PubMed Central PMCID: PMC4383662.

select

Gad E, Rastetter L, Slota M, Koehnlein M, Treuting PM, Dang Y, Stanton S, Disis ML. Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models. Breast Cancer Res Treat. 2014 Dec;148(3):501-10. doi: 10.1007/s10549-014-3199-9. Epub 2014 Nov 14. PubMed PMID: 25395320; PubMed Central PMCID: PMC4280094.

select

Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer. J Transl Med. 2014 May 10;12:121. doi: 10.1186/1479-5876-12-121. PubMed PMID: 24886063; PubMed Central PMCID: PMC4022541.

select

Disis ML, Stanton SE. Can immunity to breast cancer eliminate residual micrometastases?. Clin Cancer Res. 2013 Dec 1;19(23):6398-403. doi: 10.1158/1078-0432.CCR-13-0734. PubMed PMID: 24298070; PubMed Central PMCID: PMC3864755.

select

Stanton SE, Blanck JK, Locker J, Schreiber-Agus N. Rybp interacts with Hippi and enhances Hippi-mediated apoptosis. Apoptosis. 2007 Dec;12(12):2197-206. doi: 10.1007/s10495-007-0131-3. PubMed PMID: 17874297.

select

Stanton SE, McReynolds LJ, Evans T, Schreiber-Agus N. Yaf2 inhibits caspase 8-mediated apoptosis and regulates cell survival during zebrafish embryogenesis. J Biol Chem. 2006 Sep 29;281(39):28782-93. doi: 10.1074/jbc.M603348200. Epub 2006 Aug 4. PubMed PMID: 16891308.

select

Lindblad-Toh K, Tanenbaum DM, Daly MJ, Winchester E, Lui WO, Villapakkam A, Stanton SE, Larsson C, Hudson TJ, Johnson BE, Lander ES, Meyerson M. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol. 2000 Sep;18(9):1001-5. doi: 10.1038/79269. PubMed PMID: 10973224.

select

Stanton SE, Shin SW, Johnson BE, Meyerson M. Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas. Genes Chromosomes Cancer. 2000 Mar;27(3):323-31. doi: 10.1002/(sici)1098-2264(200003)27:3<323::aid-gcc14>3.0.co;2-p. PubMed PMID: 10679923.